Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides

Journal of Infectious Diseases

Volumn 186, Issue 10, 2002, Pages 1422-1429

  Finn, Adam ^a   Zhang, Qibo ^a   Seymour, Lynn ^a   Fasching, Claudine ^c   Pettitt, Emily ^b,d   Janoff, Edward N ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d General Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BREAST MILK; DOSE RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; NORMAL HUMAN; PRIORITY JOURNAL; PROTECTION; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA;

BACTERIAL ADHESION; FEMALE; HUMANS; IMMUNOGLOBULIN A; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MILK, HUMAN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0037111079     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344356     Document Type: Article

References (35)

1. Sleeman K, Knox K, George R, et al. Invasive pneumococcal disease in England and Wales: Vaccination implications. J Infect Dis 2001;183:239-46.
2. Karstaedt AS, Khoosal M, Crewe-Brown HH. Pneumococcal bacteremia during a decade in children in Soweto, South Africa. Pediatr Infect Dis J 2000;19:454-7.
3. Black SB, Shinefield H, Hansen J, Elvin k. Laufer D, Malinoski F. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001;20:1105-7.
4. Choo S, Finn A. New pneumococcal vaccines for children. Arch Dis Child 2001;84:289-94.
5. Shahid NS. Steinhoff MC, Hoque SS, Begum T, Thompson C, Siber GR. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 1995;346:1252-7.
6. Choo S, Zhang Q, Seymour L, Akhtar S, Finn A. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants. J Infect Dis 2000;182:1260-3.
7. Janoff EN, Fasching C, Orenstein JM, et al. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes. J Clin Invest 1999;104:1139-47.
8. Johnson S, Opstad NL, Douglas JM, Janoff EN. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides. Infect Immun 1996;64:4339-44.
9. Steinitz M, Tamir S, Ferne M, Goldfarb A. A protective human monoclonal IgA antibody produced in vitro: Anti-pneumococcal antibody engendered by Epstein-Barr virus-immortalized cell line. Eur J Immunol 1986;16:187-93.
10. van der Pol W, Vidarsson G, Vile HA, van de Winkel JG, Rodriguez ME. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcαRI (CD89). J Infect Dis 2000;182:1139-45.
11. Goldblatt D, Vaz AR, Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization, J Infect Dis 1998;177:1112-5.
12. Gregory RL, Rundegren J, Arnold RR. Separation of human IgA1 and IgA2 using jacalin-agarose chromatography. J Immunol Methods 1987;99:101-6.
13. van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG. IgA and the IgA Fc receptor. Trends Immunol 2001;22:205-11.
14. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999;180:1171-6.
15. Dagan R, Fraser D. Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: Herd immunity and reduction of otitis morbidity. Pediatr Infect Dis J 2000;19:S79-88.
16. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
17. Glass RI, Svennerholm AM, Stoll BJ, et al. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med 1983;308:1389-92.
18. Nayak N, Ganguly NK, Walia BN, Wahl V, Kanwar SS, Mahajan RC. Specific secretory IgA in the milk of Giardia lamblia-infected and uninfected women. J Infect Dis 1987;155:724-7.
19. Hayani KC, Guerrero ML, Morrow AL, et al. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants. J Pediatr 1992;121:852-6.
20. Carson PJ, Schut RL, Simpson ML, O'Brien J, Janoff EN. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J Infect Dis 1995;172:340-5.
21. Lue C, Tarkowski A, Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol 1988;140:3793-800.
22. Tarkowski A, Lue C, Moldoveanu Z, Kiyono H, McGhee JRMJ. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J Immunol 1990;144:3770-8.
23. Gasparoni A, Avanzini A, Ravagni PF, Chirico G, Rondini G, Severi F. IgG subclasses compared in maternal and cord serum and breast milk. Arch Dis Child 1992;67:41-3.
24. Nieminen T, Kayhty H, Virolainen A, Eskola J. Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. Vaccine 1998;16:313-9.
25. Svennerholm AM, Hanson LA, Holmgren J, Lindblad BS, Nilsson B, Quereshi F. Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect Immun 1980;30:427-30.
26. Russell MW, Kilian M, Lamm ME. Biological activities of IgA. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology. San Diego: Academic Press, 1999:225-40.
27. Mestecky J, Russell MW. Mucosal immunoglobulins and their contribution to defence mechanisms: An overview. Biochem Soc Trans 1997;25:457-62.
28. Kilian M, Mestecky J, Russell MW. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev 1988;52:296-303.
29. Rijneveld AW, Florquin S, Branger J, Speelman P, Van Deventer S, van der Poll T. TNF-(alpha) compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol 2001;167:5240-6.
30. Fillion I, Ouellet N, Simard M. Bergeron Y, Sato S, Bergeron MG. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment. J Immunol 2001;166:7353-61.
31. Dallaire F, Ouellet N, Bergeron Y, et al. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J Infect Dis 2001;184:292-300.
32. Weisbart RH, Kacena A, Scruh A, Golde DW, GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 1988;332:647-8.
33. Abu-Harb M, Bell F, Finn A, et al. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J 1999;14:139-43.
34. Brussow H, Barclay D, Sidoti J, et al. Effect of malnutrition on serum and milk antibodies in Zairian women. Clin Diagn Lab Immunol 1996;3:37-41.
35. Rapola S, Jantti V, Haikala R, et al. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media, J Infect Dis 2000;182:1146-52.